Published in Gut on January 01, 2004
Trichuris suis therapy in Crohn's disease. Gut (2005) 4.05
Helminth infections and host immune regulation. Clin Microbiol Rev (2012) 2.02
Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis (2010) 1.85
Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice. Infect Immun (2005) 1.45
Helminths and harmony. Gut (2004) 1.41
Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis. J Immunol (2007) 1.41
Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production. J Immunol (2008) 1.35
Helminth-primed dendritic cells alter the host response to enteric bacterial infection. J Immunol (2006) 1.16
Parasitic helminths: new weapons against immunological disorders. J Biomed Biotechnol (2010) 1.13
Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice. Infect Immun (2009) 1.06
Anti-Inflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model. Infect Immun (2008) 1.06
Helminth infections and intestinal inflammation. World J Gastroenterol (2008) 1.00
Role of helminths in regulating mucosal inflammation. Springer Semin Immunopathol (2005) 0.97
Where are we on worms? Curr Opin Gastroenterol (2012) 0.96
Nippostrongylus-induced intestinal hypercontractility requires IL-4 receptor alpha-responsiveness by T cells in mice. PLoS One (2012) 0.94
Immune evasion, immunopathology and the regulation of the immune system. Pathogens (2013) 0.94
Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. BMC Med (2015) 0.93
Taenia crassiceps infection attenuates multiple low-dose streptozotocin-induced diabetes. J Biomed Biotechnol (2010) 0.92
Worms and the treatment of inflammatory bowel disease: are molecules the answer? Clin Dev Immunol (2008) 0.91
Acute distal colitis impairs gastric emptying in rats via an extrinsic neuronal reflex pathway involving the pelvic nerve. Gut (2006) 0.91
MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitis. PLoS One (2012) 0.89
Excretory/secretory products from Trichinella spiralis adult worms ameliorate DSS-induced colitis in mice. PLoS One (2014) 0.89
Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome. Acta Pharmacol Sin (2015) 0.84
Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice. World J Gastroenterol (2010) 0.83
Schistosoma mansoni infection but not egg antigen promotes recovery from colitis in outbred NMRI mice. Dig Dis Sci (2010) 0.82
Helminthes and insects: maladies or therapies. Parasitol Res (2014) 0.81
Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel disease. Parasit Vectors (2011) 0.81
Worm proteins of Schistosoma mansoni reduce the severity of experimental chronic colitis in mice by suppressing colonic proinflammatory immune responses. PLoS One (2014) 0.80
Schistosoma mansoni Soluble Egg Antigens Induce Expression of the Negative Regulators SOCS1 and SHP1 in Human Dendritic Cells via Interaction with the Mannose Receptor. PLoS One (2015) 0.80
The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils. Mucosal Immunol (2015) 0.78
Schistosome: its benefit and harm in patients suffering from concomitant diseases. J Biomed Biotechnol (2011) 0.78
Will worms really cure Crohn's disease? Gut (2005) 0.78
Investigational new drugs in the treatment of inflammatory bowel disease: a review. J Exp Pharmacol (2011) 0.75
Helminth Immunomodulation in Autoimmune Disease. Front Immunol (2017) 0.75
Helminths in the gastrointestinal tract as modulators of immunity and pathology. Am J Physiol Gastrointest Liver Physiol (2017) 0.75
Functional diversity of helper T lymphocytes. Nature (1996) 18.09
Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol (1982) 10.99
The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med (2002) 9.26
Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology (1989) 7.59
Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89
Experimental models of inflammatory bowel disease. Gastroenterology (1995) 6.28
The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology (1965) 5.24
Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet (1996) 4.23
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology (1998) 4.12
Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med (2000) 4.09
Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology (1994) 3.60
Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev (1989) 3.21
Inflammatory bowel disease and domestic hygiene in infancy. Lancet (1994) 3.08
Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol (1999) 2.92
The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology (1996) 2.41
Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol (2002) 2.28
Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. J Immunol (1992) 2.14
Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ (1999) 1.99
Platelet-activating factor and interleukin 1 are involved in colonic dysmotility in experimental colitis in rats. Gastroenterology (1993) 1.97
Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun (2002) 1.89
Epidemiology of inflammatory bowel disease. Epidemiol Rev (1986) 1.84
Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol (1996) 1.76
An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol (1990) 1.71
Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol (2000) 1.69
Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology (1997) 1.50
Cytokine production in patients with inflammatory bowel disease. Gut (1992) 1.50
Immunity to schistosomes: progress toward vaccine. Science (1987) 1.49
Socioeconomics of Crohn's disease: a review of epidemiology and an etiological hypothesis. Am J Gastroenterol (2000) 1.46
Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J Clin Invest (1997) 1.44
Experimental colitis in animal models. Scand J Gastroenterol (1992) 1.37
Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology (2002) 1.33
Leukotriene D4 participates in colonic transit disturbances induced by intracolonic administration of trinitrobenzene sulfonic acid in rats. Gastroenterology (1992) 1.27
Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells. J Immunol (1998) 1.25
Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Dig Dis Sci (1988) 1.24
Infant mortality and the incidence of inflammatory bowel disease. Lancet (1997) 1.23
Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris. J Exp Med (1995) 1.23
The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med (1998) 1.22
Progressive alterations in circular smooth muscle contractility in TNBS-induced colitis in rats. Neurogastroenterol Motil (1999) 1.11
On the specificity of altered muscle function in experimental colitis in rats. Gastroenterology (1993) 1.11
Acetylcholine is an indirect inhibitory transmitter in the canine ileocolonic junction. Eur J Pharmacol (1989) 1.11
Altered small intestinal smooth muscle function in Crohn's disease. Gastroenterology (1993) 1.10
Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host. Infect Immun (1999) 1.08
Altered contractility of circular and longitudinal muscle in TNBS-inflamed guinea pig ileum. Am J Physiol (1997) 1.03
Cytokine Interaction and Immune Responses during Schistosoma mansoni Infection. Parasitol Today (1998) 1.00
Immunologic basis of disease and disease regulation in schistosomiasis. Chem Immunol (1997) 0.96
Global distribution of schistosomiasis: CEGET/WHO atlas. World Health Stat Q (1984) 0.95
Schistosomiasis. Digestion (1998) 0.94
In vivo expression of cytokine mRNA in rats infected with Schistosoma mansoni. Parasite Immunol (1998) 0.89
Etiology and pathophysiology of inflammatory bowel disease--environmental factors. Hepatogastroenterology (2000) 0.89
The immunologic response of congenitally athymic rats to Schistosoma mansoni infection. I. In vivo studies of resistance. J Immunol (1983) 0.88
Effect of Schistosoma mansoni-induced granulomatous inflammation on murine gastrointestinal motility. Am J Physiol Gastrointest Liver Physiol (2001) 0.88
Nematode-induced jejunal inflammation in the ferret causes long-term changes in excitatory neuromuscular responses. J Pharmacol Exp Ther (1999) 0.86
How to express pharmacological contractions of the inflamed rat intestine. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.85
Inflammatory bowel disease in rural sub-Saharan Africa: rarity of diagnosis in patients attending mission hospitals. Digestion (1989) 0.84
Differential inflammatory modulation of canine ileal longitudinal and circular muscle cells. Am J Physiol (1999) 0.84
Epidemiology of chronic intestinal disease in middle Africa. Isr J Med Sci (1979) 0.83
Gastrointestinal pathology in South America. Isr J Med Sci (1979) 0.78
Major parasitic infections: a global review. Parasitic Diseases Programme. World Health Organization, Geneva. World Health Stat Q (1986) 0.77
[Intestinal inflammation and motility]. Gastroenterol Clin Biol (1998) 0.77
Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature (1990) 5.57
Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res (1977) 3.28
Non-adrenergic non-cholinergic relaxation mediated by nitric oxide in the canine ileocolonic junction. Eur J Pharmacol (1990) 2.04
Release of nitric oxide upon stimulation of nonadrenergic noncholinergic nerves in the rat gastric fundus. J Pharmacol Exp Ther (1991) 2.02
Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res (2001) 1.92
Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation (1998) 1.77
Spatiotemporal electrical and motility mapping of distension-induced propagating oscillations in the murine small intestine. Am J Physiol Gastrointest Liver Physiol (2005) 1.67
Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine (1992) 1.58
Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res (2000) 1.58
Impaired endothelium-dependent cholinergic coronary vasodilation in patients with angina and normal coronary arteriograms. J Am Coll Cardiol (1992) 1.50
Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer. Breast Cancer Res Treat (2004) 1.43
Evidence for a differential release of nitric oxide and vasoactive intestinal polypeptide by nonadrenergic noncholinergic nerves in the rat gastric fundus. Arch Int Pharmacodyn Ther (1993) 1.42
Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol (1989) 1.36
Prostaglandin production by rabbit isolated jejunum and its relationship to the inherent tone of the preparation. Br J Pharmacol (1976) 1.29
Reactive oxygen species induce RNA damage in human atherosclerosis. Eur J Clin Invest (2004) 1.22
Evidence for nitric oxide as mediator of non-adrenergic non-cholinergic relaxations induced by ATP and GABA in the canine gut. Br J Pharmacol (1991) 1.20
Bioassay of nitric oxide released upon stimulation of non-adrenergic non-cholinergic nerves in the canine ileocolonic junction. Br J Pharmacol (1991) 1.17
Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc Res (1999) 1.17
Inflammatory properties of recombinant tumor necrosis factor in rabbit skin in vivo. J Exp Med (1989) 1.17
Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. Br J Cancer (2006) 1.15
L-arginine-dependent production of nitrogen oxides by rat pulmonary macrophages. Eur J Pharmacol (1991) 1.14
Sequential induction of nitric oxide synthase by Corynebacterium parvum in different organs of the mouse. Br J Pharmacol (1995) 1.12
Acetylcholine is an indirect inhibitory transmitter in the canine ileocolonic junction. Eur J Pharmacol (1989) 1.11
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients. Br J Cancer (2009) 1.09
Biosynthesis of prostaglandin (PGI2) and 12L-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE) by pericardium, pleura, peritoneum and aorta of the rabbit. Prostaglandins (1979) 1.09
Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res (1998) 1.07
Cutaneous breast cancer deposits show distinct growth patterns with different degrees of angiogenesis, hypoxia and fibrin deposition. Histopathology (2003) 1.07
Triphasic sequence of neointimal formation in the cuffed carotid artery of the rabbit. Arterioscler Thromb (1992) 1.07
NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. Br J Cancer (2007) 1.06
Effect of adrenergic and nitrergic blockade on experimental ileus in rats. Br J Pharmacol (1997) 1.05
TRPV1 receptors on unmyelinated C-fibres mediate colitis-induced sensitization of pelvic afferent nerve fibres in rats. J Physiol (2008) 1.05
Blood levels of 6-oxo-prostaglandin F 1 alpha during endotoxin-induced hypotension in rabbits. Eur J Pharmacol (1980) 1.05
Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. Atherosclerosis (1996) 1.05
Vascular endothelial dysfunction. Prog Cardiovasc Dis (1997) 1.04
Acetylcholine stimulates the release of prostacyclin by rabbit aorta endothelium. J Pharm Pharmacol (1983) 1.04
The use of the double-balloon enteroscope for endoscopic retrograde cholangiopancreatography and biliary stent placement after Roux-en-Y hepaticojejunostomy. Endoscopy (2007) 1.03
Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol Motil (2004) 1.02
Schistosoma mansoni: characterization of two circulating polysaccharide antigens and the immunological response to these antigens in mouse, hamster, and human infections. Exp Parasitol (1980) 1.01
Quantitative determination of 6-Oxo-PGF1 alpha in biological fluids by gas chromatography mass spectrometry. Biomed Mass Spectrom (1980) 1.01
Nitric oxide synthase immunoreactivity in the enteric nervous system of the developing human digestive tract. Cell Tissue Res (1994) 1.00
Catamenial pneumothorax caused by thoracic endometriosis. Ann Thorac Surg (1996) 1.00
Involvement of nitric oxide in the inhibitory innervation of the human isolated colon. Gastroenterology (1993) 1.00
Evidence that mast cell degranulation, histamine and tumour necrosis factor alpha release occur in LPS-induced plasma leakage in rat skin. Br J Pharmacol (1999) 0.99
Selective M3 muscarinic receptor antagonists inhibit smooth muscle contraction in rabbit trachea without increasing the release of acetylcholine. J Pharmacol Exp Ther (1992) 0.98
A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology (2007) 0.98
Epithelioid sarcoma of the vulva. Gynecol Oncol (1999) 0.98
The role of nitric oxide in inhibitory non-adrenergic non-cholinergic neurotransmission in the canine lower oesophageal sphincter. Br J Pharmacol (1991) 0.98
Lung serotonin uptake kinetics from indicator-dilution and constant-infusion methods. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.98
Immunoelectron microscopical localization of a circulating antigen in the excretory system of Schistosoma mansoni. Ultrastructural localization studies of the excretory system of S. mansoni. Parasitol Res (1995) 0.98
5-hydroxytryptamine and platelet aggregation. Fed Proc (1983) 0.97
Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer. Br J Cancer (2005) 0.97
Activated complement and anaphylatoxins increase the in vitro production of prostacyclin by rabbit aorta endothelium. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.97
Influence of endotoxin on arachidonate metabolism in isolated rabbit peritoneum. Biochem Pharmacol (1983) 0.97
Formation of prostanoids during intravascular complement activation in the rabbit. Br J Pharmacol (1985) 0.97
Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta. Br J Pharmacol (1988) 0.96
Role of oxidative stress in the pathogenesis of septic ileus in mice. Neurogastroenterol Motil (2005) 0.96
Prostaglandin F2 alpha in benign and malignant breast tumours. Br J Cancer (1985) 0.96
Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer. Br J Cancer (2006) 0.96
Transrectal ultrasound study of the pathogenesis of solitary rectal ulcer syndrome. Gut (1993) 0.95
Different pro-inflammatory profiles of interleukin 1 (IL 1) and tumor necrosis factor (TNF) in an in vivo model of inflammation. Agents Actions (1989) 0.95
Antioxidants increase the formation of 6-oxo-PGF1 alpha by ram seminal vesicle microsomes. Biochem Pharmacol (1981) 0.95
Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. Br J Cancer (2008) 0.95
Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer. J Pathol (2007) 0.95
Localization of extracellular superoxide dismutase in rat lung: neutrophils and macrophages as carriers of the enzyme. Free Radic Biol Med (1998) 0.95
Pharmacological similarity between nitric oxide and the nitrergic neurotransmitter in the canine ileocolonic junction. Eur J Pharmacol (1994) 0.94
Pharmacological characterization of 5-hydroxytryptamine receptors in the canine terminal ileum and ileocolonic junction. J Pharmacol Exp Ther (1990) 0.94
Release of prostaglandins and incapacitation after injection of endotoxin in the knee joint of the dog. Br J Pharmacol (1975) 0.94
Intimal deposition of functional von Willebrand factor in atherogenesis. Arterioscler Thromb Vasc Biol (1999) 0.94
Altered Ca2+ handling of smooth muscle cells in aorta of apolipoprotein E-deficient mice before development of atherosclerotic lesions. Cell Calcium (2006) 0.93
Light and electron microscope studies on extravascular Trypanosoma brucei gambiense in the brain of chronically infected rodents. Ann Soc Belg Med Trop (1981) 0.93
Release and vascular activity of endothelium-derived relaxing factor in atherosclerotic rabbit aorta. Eur J Pharmacol (1990) 0.93